🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Healthy Subjects;Overweight or Obesity

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity NCT07437079Phase 11 site📍 Lenexa Novo Nordisk A/S · Tests: NNC6989-0001, Placebo (NNC6989-0001) A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects NCT07102251Phase 11 site📍 Hefei Sunshine Lake Pharma Co., Ltd. · Tests: HEC-007 injection, Placebo, HEC-007 injection, Placebo IBI3042 Study in Healthy Participants and Overweight or Obese Participants NCT07793019Phase 11 site📍 Beijing Innovent Biologics (Suzhou) Co. Ltd. · Tests: Orforglipron, Matching Placebo, IBI3042 A Study to Evaluate MWN109 Injection in Healthy Subjects NCT06859853Phase 11 site📍 Melbourne Shanghai Minwei Biotechnology Co., Ltd · Tests: Placebo, Subcutaneous single and mutiple dose Phase I Study of XTL6001 Injection in Healthy and Obese Subjects NCT07205432Phase 11 site📍 Beijing Shanghai Xitaili Biomedicine Technology co., Ltd. · Tests: XTL6001, Placebo A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants NCT07784699Phase 11 site📍 Beijing Gan & Lee Pharmaceuticals. · Tests: GZC8072 Tablets, Placebo A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide NCT07793929Phase 12 sites📍 Orlando📍 San Antonio Kailera · Tests: Ribupatide A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. NCT07511205Phase 13 sites📍 Glendale📍 Brooklyn📍 Harrow AstraZeneca · Tests: AZD1043, Placebo Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers NCT07184502Phase 12 sites📍 Brisbane📍 Melbourne Beijing QL Biopharmaceutical Co.,Ltd · Tests: ZT003 - Part1 (Single ascending dose ), ZT003 - Part 2(Multiple ascending dose ) Pistachio Snacking and Metabolic Flexibility NCT07340125NA1 site📍 Columbia University of South Carolina · Tests: Pistachio A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity NCT07578584Phase 11 site📍 Neuss Novo Nordisk A/S · Tests: NNC0497-0040, Placebo A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy Participants NCT07532655Phase 11 site📍 Nedlands CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: SYH2082 Injection, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy